J. C. F. Nogueira

Functionalised thermally induced phase separation (TIPS) microparticles enabled for “click” chemistry† †Electronic supplementary information (ESI) available. See DOI: 10.1039/d0ob00106f

Daniel A. Richards, F. Di Maggio, V. Chudasama, 2020, Organic & biomolecular chemistry.

Oriented attachment of VNAR proteins, via site-selective modification, on PLGA–PEG nanoparticles enhances nanoconjugate performance† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9cc02655j

Daniel A. Richards, V. Chudasama, C. Barelle, 2019, Chemical communications.

Forming next-generation antibody–nanoparticle conjugates through the oriented installation of non-engineered antibody fragments† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc02747h

Katrina Campbell, Vijay Chudasama, Peter Smyth, 2017, Chemical science.

Employing defined bioconjugates to generate chemically functionalised gold nanoparticles for in vitro diagnostic applications†

Daniel A. Richards, Michael R. Thomas, M. Stevens, 2021, Nanoscale.

Site-selective protein modification via disulfide rebridging for fast tetrazine/trans-cyclooctene bioconjugation.

T. Weil, Marco Raabe, V. Chudasama, 2020, Organic & biomolecular chemistry.

A plug-and-play approach for the de novo generation of dually functionalised bispecifics.

S. Caddick, V. Chudasama, A. Maruani, 2019, Bioconjugate chemistry.

Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody

Mark E. B. Smith, S. Caddick, V. Chudasama, 2017 .

Refined construction of antibody-targeted nanoparticles leads to superior antigen binding and enhanced delivery of an entrapped payload to pancreatic cancer cells.

J. F. Burrows, Daniel A. Richards, D. Longley, 2020, Nanoscale.